| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5527814 | COVIS | Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis |
Jun, 2013
(10 years ago) | |
Rilutek is owned by Covis.
Rilutek contains Riluzole.
Rilutek has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Rilutek are:
- US5527814
Rilutek was authorised for market use on 12 December, 1995.
Rilutek is available in tablet;oral dosage forms.
The generics of Rilutek are possible to be released after 18 June, 2013.
Drugs and Companies using RILUZOLE ingredient
Market Authorisation Date: 12 December, 1995
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
RILUTEK family patents
